08/02/2022
Pleased to be referenced for our advanced development of PT-001 for Pulmonary Arterial Hypertension (PAH) in 's 2022 Pipeline report! https://www.yahoo.com/now/pulmonary-hypertension-clinical-trials-pipeline-170000041.html
DelveInsight